Cover: What We Can--And Cannot--Expect from School-Based Drug Prevention

What We Can--And Cannot--Expect from School-Based Drug Prevention

Published in: Drug and Alcohol Review, v. 23, no. 1, Mar. 2004, p. 79-87

Posted on 2004

by Jonathan P. Caulkins, Rosalie Liccardo Pacula, Susan M. Paddock, James Chiesa

School-based drug prevention is a central component of drug control strategies. This paper assesses quantitatively its contributions in the United States from a social policy perspective. The social benefits per participant stemming from reduced drug use (~$840 from tobacco, alcohol, cocaine and marijuana) appear to exceed the economic costs of running the programs (~$150 per participant); while the benefits associated with reduced cocaine use alone (~$300) exceed the costs, the corresponding figure for marijuana (~$20) is small. Even if prevention reduced the use of other illicit drugs (e.g. heroin) by as much as it reduced use of cocaine, the majority of benefits would still stem from reductions in use of tobacco and alcohol, which has implications for how school-based drug prevention is funded and whether it is perceived more as a weapon in the war on illicit drugs or as a public health measure. Specific numeric results are subject to considerable uncertainty, but the basic character of the conclusions appears to be robust with respect to parameter uncertainty. The greatest uncertainties concern the permanence of prevention's effects and how to value instances of initiation being deferred but not completely prevented.

This report is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.